178 related articles for article (PubMed ID: 18310474)
1. Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture.
Kim HJ; Waataja JJ; Thayer SA
J Pharmacol Exp Ther; 2008 Jun; 325(3):850-8. PubMed ID: 18310474
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture.
Kouznetsova M; Kelley B; Shen M; Thayer SA
Mol Pharmacol; 2002 Mar; 61(3):477-85. PubMed ID: 11854427
[TBL] [Abstract][Full Text] [Related]
3. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure.
Hoffman AF; Oz M; Caulder T; Lupica CR
J Neurosci; 2003 Jun; 23(12):4815-20. PubMed ID: 12832502
[TBL] [Abstract][Full Text] [Related]
4. Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss.
Kim HJ; Shin AH; Thayer SA
Mol Pharmacol; 2011 Sep; 80(3):357-66. PubMed ID: 21670103
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
Sim-Selley LJ; Martin BR
J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
[TBL] [Abstract][Full Text] [Related]
6. Delta(9)-Tetrahydrocannabinol-induced desensitization of cannabinoid-mediated inhibition of synaptic transmission between hippocampal neurons in culture.
Lundberg DJ; Daniel AR; Thayer SA
Neuropharmacology; 2005 Dec; 49(8):1170-7. PubMed ID: 16157354
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal.
Huang H; Acuna-Goycolea C; Li Y; Cheng HM; Obrietan K; van den Pol AN
J Neurosci; 2007 May; 27(18):4870-81. PubMed ID: 17475795
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
Kim D; Thayer SA
J Neurosci; 2001 May; 21(10):RC146. PubMed ID: 11319244
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus.
Freiman I; Szabo B
Neuroscience; 2005; 133(1):305-13. PubMed ID: 15893652
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.
Ohno-Shosaku T; Tsubokawa H; Mizushima I; Yoneda N; Zimmer A; Kano M
J Neurosci; 2002 May; 22(10):3864-72. PubMed ID: 12019305
[TBL] [Abstract][Full Text] [Related]
11. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
Shen M; Thayer SA
Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
Ihenetu K; Molleman A; Parsons ME; Whelan CJ
Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
[TBL] [Abstract][Full Text] [Related]
14. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
Araya KA; David Pessoa Mahana C; González LG
Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
[TBL] [Abstract][Full Text] [Related]
15. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus.
Blair RE; Deshpande LS; Sombati S; Falenski KW; Martin BR; DeLorenzo RJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1072-8. PubMed ID: 16469864
[TBL] [Abstract][Full Text] [Related]
16. Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices.
Ameri A; Simmet T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):265-72. PubMed ID: 10731038
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release.
Földy C; Neu A; Jones MV; Soltesz I
J Neurosci; 2006 Feb; 26(5):1465-9. PubMed ID: 16452670
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.
Szabo B; Dörner L; Pfreundtner C; Nörenberg W; Starke K
Neuroscience; 1998 Jul; 85(2):395-403. PubMed ID: 9622239
[TBL] [Abstract][Full Text] [Related]
19. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
Hoffman AF; Riegel AC; Lupica CR
Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
Duncan M; Kendall DA; Ralevic V
J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
